1931 — Ethk Labs Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapValue Trap

Annual income statement for Ethk Labs, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,731	2,749	3,088	3,162	2,821
Cost of Revenue
Gross Profit	566	608	672	751	566
Selling / General / Administrative Expenses
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2,464	2,423	2,686	2,695	2,640
Operating Profit	267	326	403	468	181
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	268	284	339	402	88.2
Provision for Income Taxes
Net Income After Taxes	162	196	237	266	37.4
Minority Interest
Net Income Before Extraordinary Items
Net Income	175	210	238	260	34.9
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	175	210	238	260	34.9
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.137	0.165	0.177	0.174	0.021
Dividends per Share